ArticlePharmacoEconomics2024

Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study.

Jason Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.